Cancer drug shortages across India have prompted the government to approve higher prices for select chemotherapy medicines and anti-tetanus shots. The move aims to restore supplies disrupted by rising production costs and raw material shortages. However, experts warn that increased prices may further strain cancer patients already facing expensive treatment costs.